Centers For Age Control

AgeMeter® cloud testing app is central for $multi-trillion aging-reversal industry

Print
Follow Claim My Business
Security Type
CAFES
Categories
Technology, Infrastructure, Healthcare & Medical, Community & Lifestyle
Min Investment
$100
Location
Las Vegas, NV
Offering Date
July 20, 2021
Expected Close Date
April 30, 2023
Target Raise
$50.00K-$250.00K
No. Investors
100
Security Price
$1
Website
agemeter.com
Number of Employees
1
Cash
$18,219
Revenue
$72,874
Short Term Debt
$90,306
Cost of Goods
$37,759
Long Term Debt
$74,700
Net Income
$5,872

Company Description

The AgeMeter® calculates functional age by noninvasively testing the body’s physiological biomarkers. With our new HealthMeter™ kit, we can analyze 16 physiological Covid-19 risk factors and indicators, as well. The AgeMeter can provide substantial income for medical practices, fitness centers, and hospital systems, and be a valuable tool for researchers, universities, and individuals interested in warding off the effects of aging.

Key Deal Facts

The only reputable, noninvasive device that calculates the age at which a person's body actually functions.
AgeMeter® already in North America, Central America, South America, Europe, Asia, Africa, & Oceania
AgeMeter® is used by doctors, researchers & individuals who can measure & monitor their aging-reversal health programs.
Endorsed by the world's top scientists, including Harvard geneticists Dr. George Church & Dr. David Sinclair.
Industry leader Neurohacker® used the AgeMeter® to validate its aging reversal nutraceutical in a March 2021 study.
Revenue from professional kit to medical practices & researchers app to individuals.
2021: Launch mobile app functional age test for individuals.

Management Team / Advisory Board Bios

Elliott Small, Founder and CEO
Harvard BA Biochemistry. 4 patents: 3 issued: Rapid Battery Charging, 1 pending: Aging Reversal Methods & Compositions. Chemist: Kraft Foods. Computer Programmer. A passion for a youthful life through aging reversal.

Dr. Edward Layne, Medical Director, MD, SCM
A graduate of Harvard College, Tulane Medical School, Harvard Medical School Post-grad, Dr. Layne currently serves as Medical Director at AgeMeter, and is the founder of 3 gastro and nutritional clinics, in the Atlanta, GA region.

Taylor Speegle, Chief Technology Officer
As CTO, Taylor is passionate about AgeMeter's mission to improve the quality of life for aging adults. He is also currently the managing partner of the award-winning MakerMonster design agency and is alumnus of Loyola Marymount Univ.
Amount Raised : $106,377
Reveal the Score by Voting
_
0
Business Idea
Business Traction
Management Team
Valuation

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments